The Bengaluru-based firm has scored an early win among its peers with the UK approval for the first generic version of liraglutide injectible, which is losing patent protection in November.from Moneycontrol Business News https://ift.tt/Gb4E0Cr
Sunday, April 7, 2024
Biocon leads India push into weight loss drugs as patents lapse
The Bengaluru-based firm has scored an early win among its peers with the UK approval for the first generic version of liraglutide injectible, which is losing patent protection in November.from Moneycontrol Business News https://ift.tt/Gb4E0Cr
Subscribe to:
Post Comments (Atom)
LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally
A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...
-
By BY BEN HUBBARD AND AURELIEN BREEDEN from NYT World https://ift.tt/3oyLkdW >
-
By STEPHANIE SAUL from NYT U.S. https://nyti.ms/2WdcYAk >
No comments:
Post a Comment